Culture Condition of Bone Marrow Stromal Cells Affects Quantity and Quality of the Extracellular Vesicles.
AuthorScheiber, Amanda L
Clark, Cierra A
Horwitz, Edwin M
Kawasawa, Yuka Imamura
JournalInternational Journal of Molecular Sciences
MetadataShow full item record
AbstractExtracellular vesicles (EVs) released by bone marrow stromal cells (BMSCs) have been shown to act as a transporter of bioactive molecules such as RNAs and proteins in the therapeutic actions of BMSCs in various diseases. Although EV therapy holds great promise to be a safer cell-free therapy overcoming issues related to cell therapy, manufacturing processes that offer scalable and reproducible EV production have not been established. Robust and scalable BMSC manufacturing methods have been shown to enhance EV production; however, the effects on EV quality remain less studied. Here, using human BMSCs isolated from nine healthy donors, we examined the effects of high-performance culture media that can rapidly expand BMSCs on EV production and quality in comparison with the conventional culture medium. We found significantly increased EV production from BMSCs cultured in the high-performance media without altering their multipotency and immunophenotypes. RNA sequencing revealed that RNA contents in EVs from high-performance media were significantly reduced with altered profiles of microRNA enriched in those related to cellular growth and proliferation in the pathway analysis. Given that pre-clinical studies at the laboratory scale often use the conventional medium, these findings could account for the discrepancy in outcomes between pre-clinical and clinical studies. Therefore, this study highlights the importance of selecting proper culture conditions for scalable and reproducible EV manufacturing.
Identifier to cite or link to this itemhttp://hdl.handle.net/10713/18011
- microRNA-148a-3p in extracellular vesicles derived from bone marrow mesenchymal stem cells suppresses SMURF1 to prevent osteonecrosis of femoral head.
- Authors: Huang S, Li Y, Wu P, Xiao Y, Duan N, Quan J, Du W
- Issue date: 2020 Oct
- BMSC-derived extracellular vesicles intervened the pathogenic changes of scleroderma in mice through miRNAs.
- Authors: Jin J, Ou Q, Wang Z, Tian H, Xu JY, Gao F, Hu S, Chen J, Wang J, Zhang J, Lu L, Jin C, Xu GT, Zhao J
- Issue date: 2021 Jun 5
- A Good Manufacturing Practice-grade standard protocol for exclusively human mesenchymal stromal cell-derived extracellular vesicles.
- Authors: Pachler K, Lener T, Streif D, Dunai ZA, Desgeorges A, Feichtner M, Öller M, Schallmoser K, Rohde E, Gimona M
- Issue date: 2017 Apr
- Extracellular vesicles from GPNMB-modified bone marrow mesenchymal stem cells attenuate bone loss in an ovariectomized rat model.
- Authors: Huang B, Su Y, Shen E, Song M, Liu D, Qi H
- Issue date: 2021 May 1
- Purity Determines the Effect of Extracellular Vesicles Derived from Mesenchymal Stromal Cells.
- Authors: Forteza-Genestra MA, Antich-Rosselló M, Calvo J, Gayà A, Monjo M, Ramis JM
- Issue date: 2020 Feb 12